Evan Lebois

Evan has 10 years of experience discovering and developing small molecule drugs for diseases of the central nervous system (CNS). His work has spanned multiple modes of pharmacology, target classes, and therapeutic areas with a particular focus on neurodegenerative and neuropsychiatric diseases. He is a trained neuroscientist, pharmacologist, and medicinal chemist who has led drug discovery teams across all stages of preclinical development through translational and early clinical development. Additionally, he has held prior roles of increasing seniority at Pfizer, the Broad Institute of Harvard and MIT, and most recently at Nido Biosciences. To-date, he has helped deliver 7 preclinical candidates for clinical development with 4 of these programs actively undergoing clinical trials. Evan holds a PhD in neuroscience from Emory University. Outside of work Evan loves to run ultra-distance trail races, cook, garden, and play both games and music.